Effect of doxorubicin on Wild-Type and deoxyadenosine-resistant mouse leukemia L1210 cells

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 891-895

  He, Ai Wu Ruth ^a   Cory, Joseph G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Deoxyadenosine; Doxorubicin; Leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYADENOSINE DERIVATIVE; DOXORUBICIN; MESSENGER RNA; RNA;

ANIMAL; ARTICLE; CELL CULTURE; CELL CYCLE; DNA DAMAGE; DRUG EFFECT; DRUG RESISTANCE; FLOW CYTOMETRY; GENETICS; LEUKEMIA L 1210; MOUSE; PATHOLOGY; RADIATION EXPOSURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; DEOXYADENOSINES; DNA DAMAGE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; LEUKEMIA L1210; MICE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0033125117     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.891     Document Type: Article

References (23)

1. Hartwell LH and Weinert TA: Checkpoints: controls that ensure the order of the cell cycle events. Science 246: 629-634, 1989.
2. Pines J and Hunter T: Human cell division: the involvement of cyclins A and B1, and multiple cdc2s. Cold Spring Harb Symp Quant Biol 56: 449-463, 1991.
3. Arion D, Meijer L, Brizuela L and Beach D: cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF. Cell 55: 371-378, 1988.
4. Gould KL and Nurse P: Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342: 39-45, 1989.
5. Xiong Y, Hannon GJ, Zhang Z, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
6. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
7. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang YS, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B: Waf1/cip1 is induced in p53 mediated G(1) arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
8. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and Gadd45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992.
9. Miyashita T, Krajewski S, Krajewska M, Want HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of Bcl-2 and Bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
10. Dulic VK, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023, 1994.
11. Yonish-Rouach E, Resnitzky D, Loten J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 353: 345-347, 1991.
12. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WT and Givol D: Induction of WAF1/CIP1 by a p53-independent pathway: Cancer Res 54: 3391-3395, 1994.
13. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroth AB and Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674, 1995.
14. Carter GL and Cory JG: Selective resistance of L1210 cell lines to inhibitors of ribonucleotide reductase. Adv Enzyme Regul 29: 123-139, 1989.
15. Cory JG, Cory AH, Long SD, Carter GL and Johnson CE: Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine. Cancer Res 52: 2000-2003, 1992.
16. Cory JG, He AW and Cory AH: Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53. Anticancer Res 16: 3483-3490, 1996.
17. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
18. Krishan A, Paika K and Frei E III: Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J Cell Biol 66: 521-530, 1975.
19. He AWR and Cory JG: Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells. Oncol Res (In press).
20. Cory JG and Carter GL: Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors. Cancer Res 48: 839-843, 1988.
21. Carter GL and Cory JG: Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells. Cancer Res 48: 5796-5799, 1988.
22. Cory AH, Sato A, Thompson DP and Cory JG: Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone. Oncol Res 8: 449-456, 1996.
23. He AWR and Cory JG: p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines. Anticancer Res (In press).